prof. dr. E. (Eelko) Hak
Full professor of Clinical Pharmacoepidemiology
Methodology of (un)intentional drug/vaccine effect research with "real-world Big Data" (e.g. case-control, case-only, sibling designs, instrumental variable analysis, propensity score analysis, also in combination with cost-effectiveness research and in relation to Precision Medicine. Clinical epidemiology of (respiratory) infections, antibiotic treatment and vaccination. Implementation research of medication/vaccine strategies (adherence, persistence) in public health.
Additional activities: Honorary professor at department of Epidemiology, UMC Groningen. Director consultancy Epicoach V.O.F. (see www.epicoach.nl). Member of the Dutch Health Council Vaccinations and Health Council Influenza vaccination. Member (methodologist) of Medical Ethical Review Board BEBO, Assen (evaluates >60% of phase 1 clinical drug trials in NL). Deputy director master Medical Pharmaceutical Sciences (MPS, Keuzegids 2017: Top-rated program, see www.rug.nl\masters\MPS ). Co-chair GUIDE graduate school research group Real-world studies in Pharmaco-Epidemiology, -Genetics, -Economics & -Therapy (PEGET). Work Package leader clinical vaccine trial program FP7-project UNISEC. Member of the Faculty Council Faculty of Science and Engineering.
|Last modified:||02 May 2019 07.40 a.m.|